Bollard Group’s Accendra Health ACH Stock Holding History

Bollard Group’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,000	Closed	-$78K	–	295
2024 Q3	$78K	Hold	5,000	–	–	﹤0.01%	221
2024 Q2	$67K	Hold	5,000	–	–	﹤0.01%	217
2024 Q1	$139K	Hold	5,000	–	–	﹤0.01%	179
2023 Q4	$96K	Hold	5,000	–	–	﹤0.01%	189
2023 Q3	$81K	Hold	5,000	–	–	﹤0.01%	193
2023 Q2	$95K	Hold	5,000	–	–	﹤0.01%	193
2023 Q1	$73K	Buy	+5,000	New	+$89.6K	﹤0.01%	203

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group's ACH Position: Q4 2024 in Review

Bollard Group sold out of Accendra Health (ACH) in Q4 2024, closing a stake of 5,000 shares — an estimated $78K sold.

Bollard Group first reported a position in ACH in Q1 2023 and held it in 7 quarters. The position peaked at $139K in Q1 2024. 198 funds tracked by Wall St. Rank hold ACH as of Q4 2024.

Bollard Group reported no remaining Accendra Health position as of Q4 2024 after selling out during the quarter.
Bollard Group sold 5,000 Accendra Health shares in Q4 2024, an estimated $78K.
Bollard Group first reported a position in Accendra Health in Q1 2023 and held it in 7 quarters.
Bollard Group's Accendra Health position peaked at $139K in Q1 2024.
198 funds tracked by Wall St. Rank held Accendra Health as of Q4 2024.

Based on Bollard Group's 13F filing for Q4 2024, filed 14 Feb 2025.